93-9472 (Pemoline 75 mg)
Pill imprint 93-9472 has been identified as Pemoline 75 mg.
Pemoline is used in the treatment of adhd and belongs to the drug class CNS stimulants. There is no proven risk in humans during pregnancy. Pemoline 75 mg is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).
Pemoline
- Imprint:
- 93-9472
- Strength:
- 75 mg
- Color:
- Orange
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- CNS stimulants
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- 4 - Some potential for abuse
- Manufacturer:
- Teva Pharmaceuticals USA
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
